Finance

Beta
Ask
Lists
SIG:ASX
Sigma Healthcare Ltd
2,64 AUD
-1,86%
(-0,050) 1D
12-июн., 16:10:16 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for SIG...
Open
2,71 AUD
High
2,74 AUD
Low
2,63 AUD
Mkt. cap
30,48 млд
Avg. vol.
14,34 млн
Volume
25,39 млн
Dividend
1,25%
Quarterly dividend
0,01 AUD
Ex-dividend date
2026-ж., 4-мар.
52-wk high
3,28 AUD
52-wk low
2,58 AUD
Shares outstanding
11,54 млд
No. of employees
156
Open
2,71 AUD
High
2,74 AUD
Low
2,63 AUD
Mkt. cap
30,48 млд
Avg. vol.
14,34 млн
Volume
25,39 млн
Dividend
1,25%
Quarterly dividend
0,01 AUD
Ex-dividend date
2026-ж., 4-мар.
52-wk high
3,28 AUD
52-wk low
2,58 AUD
Shares outstanding
11,54 млд
No. of employees
156
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to SIG in the past 3 months
Strong Buy
Buy
8
Hold
2
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for SIG in the last 3 months.
Highest
Current 2,64 AUD
3,60 AUD (+36,36%)
Average
3,30 AUD (+25,15%)
Lowest
2,60 AUD (-1,52%)
News stories
From sources across the web
Profile
Sigma Healthcare Limited is an Australian, ASX-listed company with a focus on the pharmacy industry. The company has pharmacy operations in retail, wholesale and distribution. From its head office in Preston, Victoria, Sigma manages over 1,200 branded and independent pharmacies. Sigma Healthcare owns Australian retail pharmacy brands: Amcal, Chemist Warehouse and Discount Drug Stores. The company also has a presence in the hospital pharmacy services, contract logistics, dose administration aids and other healthcare service adjacencies. Wikipedia
About Sigma Healthcare Ltd
CEOMark Hooper | Vikesh Ramsunder
Employees156
Founded1912
HeadquartersКлейтон, Виктория, Австралия
SectorHealth care provider
Websitesigmahealthcare.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
2024-ж. сен.
2024-ж. дек.
2025-ж. сен.
2025-ж. дек.
Revenue
981,83 млн
981,83 млн
2,75 млд
2,75 млд
Cost of goods sold
643,18 млн
643,18 млн
2,25 млд
2,25 млд
Cost of revenue
643,18 млн
643,18 млн
2,25 млд
2,25 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
130,91 млн
130,91 млн
235,05 млн
235,05 млн
Operating expense
130,91 млн
130,91 млн
235,05 млн
235,05 млн
Total operating expenses
774,08 млн
774,08 млн
2,49 млд
2,49 млд
Operating income
207,75 млн
207,75 млн
268,85 млн
268,85 млн
Other non operating income
3,38 млн
3,38 млн
4,89 млн
4,89 млн
EBT including unusual items
218,40 млн
218,40 млн
268,48 млн
268,48 млн
EBT excluding unusual items
218,40 млн
218,40 млн
268,48 млн
268,48 млн
Income tax expense
64,48 млн
64,48 млн
78,96 млн
78,96 млн
Effective tax rate
29,52%
29,52%
29,41%
29,41%
Other operating expenses
-
-
-
-
Net income
154,96 млн
154,96 млн
189,91 млн
189,91 млн
Net profit margin
15,78%
15,78%
6,90%
6,90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-582,00 миң
-582,00 миң
-13,84 млн
-13,84 млн
Net interest expenses
-582,00 миң
-582,00 миң
-13,84 млн
-13,84 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
212,58 млн
212,58 млн
280,19 млн
280,19 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer